| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |